Kolexia
Thiriez Claire
Neurologie
Hôpital Côte de Nacre
Caen, France
40 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Tremblement Inflammation Dyskinésies Maladies neuro-inflammatoires Troubles de la motricité Raideur musculaire Bégaiement Ecchymose

Industries

Abbvie
2 collaboration(s)
Dernière en 2023
Pharma Dom
2 collaboration(s)
Dernière en 2023
Ipsen
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society   30 janvier 2024
Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease: A Multicentre, Open-label Study to Determine the Long Term Safety, Tolerability and Efficacy of ProSavin in Patients With Bilateral, Idiopathic Parkinson's Disease.
Essai Clinique (Axovant Sciences Ltd.)   27 avril 2022
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.
Parkinsonism & related disorders   13 juillet 2021
Increased microglial activation in patients with Parkinson disease using F-DPA714 TSPO PET imaging.
Parkinsonism & related disorders   17 novembre 2020
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.
European journal of neurology   23 octobre 2017
P comme Parkinson
Youtube @ Henri Mondor   01 octobre 2016
PREDEMPARK: Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET Scan
Essai Clinique (Assistance publique – Hôpitaux de Paris)   31 juillet 2016
SpinalPark: Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease: A Phase I Safety and Efficacy Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   31 juillet 2016
367. A Dopamine Gene Therapy for Advanced PD: 4 Years Phase I/II Clinical Update
Molecular therapy : the journal of the American Society of Gene Therapy   01 mai 2016
INFLAPARK: High Resolution PET Imaging of Microglial Activation in Parkinson's Disease (PD) With a New Tracer [18F]DPA-714
Essai Clinique (Assistance publique – Hôpitaux de Paris)   13 juillet 2015